1232PModel-based assessment of benefit-risk profile of...

Annals of Oncology 2018 / 10 Vol. 29; Iss. suppl_8

1232PModel-based assessment of benefit-risk profile of nivolumab (NIVO) flat dosing schedules (Q2W and Q4W) across multiple tumor types

Zhao, X, Shen, J, Gopalakrishnan, M, Feng, Y, Schmidt, B J, Statkevich, P, Kelleher, T, Rashford, M, Ivaturi, V, Gobburu, J V S, Agrawal, S, Bello, A, Roy, A
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy288.103
Date:
October, 2018
File:
PDF, 78 KB
english, 2018
Conversion to is in progress
Conversion to is failed